BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23263697)

  • 1. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.
    Conroy SK; McDonald BC; Smith DJ; Moser LR; West JD; Kamendulis LM; Klaunig JE; Champion VL; Unverzagt FW; Saykin AJ
    Breast Cancer Res Treat; 2013 Jan; 137(2):493-502. PubMed ID: 23263697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.
    Chen BT; Jin T; Patel SK; Ye N; Sun CL; Ma H; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Somlo G; Vazquez J; Levi A; Tan H; Yang R; Katheria V; Hurria A
    Breast Cancer Res Treat; 2018 Nov; 172(2):363-370. PubMed ID: 30088178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered neural activation during prepotent response inhibition in breast cancer survivors treated with chemotherapy: an fMRI study.
    Kam JW; Boyd LA; Hsu CL; Liu-Ambrose T; Handy TC; Lim HJ; Hayden S; Campbell KL
    Brain Imaging Behav; 2016 Sep; 10(3):840-8. PubMed ID: 26489975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.
    Wang L; Apple AC; Schroeder MP; Ryals AJ; Voss JL; Gitelman D; Sweet JJ; Butt ZA; Cella D; Wagner LI
    Cancer; 2016 Jan; 122(2):258-68. PubMed ID: 26484435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain damage following prophylactic cranial irradiation in lung cancer survivors.
    Simó M; Vaquero L; Ripollés P; Jové J; Fuentes R; Cardenal F; Rodríguez-Fornells A; Bruna J
    Brain Imaging Behav; 2016 Mar; 10(1):283-95. PubMed ID: 26015269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study.
    Correa DD; Root JC; Kryza-Lacombe M; Mehta M; Karimi S; Hensley ML; Relkin N
    Brain Imaging Behav; 2017 Dec; 11(6):1652-1663. PubMed ID: 27766586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study.
    López Zunini RA; Scherling C; Wallis N; Collins B; MacKenzie J; Bielajew C; Smith AM
    Brain Imaging Behav; 2013 Dec; 7(4):460-77. PubMed ID: 23242968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
    Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion.
    Nudelman KN; Wang Y; McDonald BC; Conroy SK; Smith DJ; West JD; O'Neill DP; Schneider BP; Saykin AJ
    PLoS One; 2014; 9(5):e96713. PubMed ID: 24816641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pupillary response: cognitive effort for breast cancer survivors.
    Myers JS; Kahya M; Mitchell M; Dai J; He J; Moon S; Hamilton K; Valla M; O'Dea A; Klemp J; Kurylo M; Akinwuntan A; Devos H
    Support Care Cancer; 2019 Mar; 27(3):1121-1128. PubMed ID: 30097791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
    Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated Hashimoto's thyroiditis.
    Quinque EM; Karger S; Arélin K; Schroeter ML; Kratzsch J; Villringer A
    Psychoneuroendocrinology; 2014 Apr; 42():188-98. PubMed ID: 24636515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study.
    Kam JWY; Brenner CA; Handy TC; Boyd LA; Liu-Ambrose T; Lim HJ; Hayden S; Campbell KL
    Clin Neurophysiol; 2016 Jan; 127(1):369-378. PubMed ID: 25868929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study.
    Zhang H; Li P; Liu T; Wang X; Feng W; Chen R; Wei H; Li G; Ning L; Zhang M; Zhang Y
    Brain Imaging Behav; 2022 Apr; 16(2):843-854. PubMed ID: 34608574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
    Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
    Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical brain MRI study of pediatric cancer survivors treated with chemotherapy: Correlation with behavioral measures.
    Cahaney C; Stefancin P; Coulehan K; Parker RI; Preston T; Goldstein J; Hogan L; Duong TQ
    Magn Reson Imaging; 2020 Oct; 72():8-13. PubMed ID: 32526251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute caffeine administration effect on brain activation patterns in mild cognitive impairment.
    Haller S; Montandon ML; Rodriguez C; Moser D; Toma S; Hofmeister J; Sinanaj I; Lovblad KO; Giannakopoulos P
    J Alzheimers Dis; 2014; 41(1):101-12. PubMed ID: 24577471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies.
    Sousa H; Almeida S; Bessa J; Pereira MG
    Neuropsychol Rev; 2020 Sep; 30(3):287-309. PubMed ID: 32607817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.